Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules |
| |
Authors: | Sung Byung-Je Hwang Kwang Yeon Jeon Young Ho Lee J I Heo Yong-Seok Kim Jin Hwan Moon Jinho Yoon Jung Min Hyun Young-Lan Kim Eunmi Eum Sung Jin Park Sam-Yong Lee Jie-Oh Lee Tae Gyu Ro Seonggu Cho Joong Myung |
| |
Institution: | Division of Drug Discovery, CrystalGenomics, Inc., Daedeok Biocommunity, Jeonmin-dong, Yuseong-gu, Daejeon, 305-390, South Korea. |
| |
Abstract: | Phosphodiesterases (PDEs) are a superfamily of enzymes that degrade the intracellular second messengers cyclic AMP and cyclic GMP. As essential regulators of cyclic nucleotide signalling with diverse physiological functions, PDEs are drug targets for the treatment of various diseases, including heart failure, depression, asthma, inflammation and erectile dysfunction. Of the 12 PDE gene families, cGMP-specific PDE5 carries out the principal cGMP-hydrolysing activity in human corpus cavernosum tissue. It is well known as the target of sildenafil citrate (Viagra) and other similar drugs for the treatment of erectile dysfunction. Despite the pressing need to develop selective PDE inhibitors as therapeutic drugs, only the cAMP-specific PDE4 structures are currently available. Here we present the three-dimensional structures of the catalytic domain (residues 537-860) of human PDE5 complexed with the three drug molecules sildenafil, tadalafil (Cialis) and vardenafil (Levitra). These structures will provide opportunities to design potent and selective PDE inhibitors with improved pharmacological profiles. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|